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Take home message  
12 weeks of high-intensity interval exercise training induces clinically meaningful effects 
on the amount and intensity of daily activities in COPD. 
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To the Editor, 
Mounting evidence suggests that Daily Activity Levels (DAL) in patients with Chronic Obstructive 
Pulmonary Disease (COPD) are markedly low compared to healthy age-matched individuals and are 
associated with poorer health status and prognosis [1]. COPD severity negatively impacts on DAL 
since patients with low DAL experience greater ventilatory, central hemodynamic and peripheral 
muscle oxygenation constrains during activities of daily living when compared to more physically 
active counterparts [2,3]. Although exercise training as part of Pulmonary Rehabilitation (PR) has 
shown to mitigate the aforementioned physiological constraints [4], there is no evidence of clinically 
meaningful improvement on DAL following PR [5] (manifested by a mean increase of at least 1000 
steps/day [6]). This has been attributed to methodological shortfalls such as lack of adequately 
controlled studies, small sample size, short duration of PR programmes, application of non-validated 
for COPD patients activity monitors [5] and insufficient exercise intensities to induce true physiological 
training effects. Interval exercise training has been shown to allow application of intense loads to 
peripheral muscles that induce substantial physiological effects manifested by mitigation of respiratory 
and central hemodynamic limitations and partial restoration of peripheral muscle dysfunction in 
patients with diverse COPD severity [7,8]. In this context it is reasoned that application of this training 
modality would allow transfer of the aforementioned physiological benefits into clinically meaningful 
improvements in DAL. Accordingly, the purpose of this randomized controlled study was to investigate 
the effect of a 12-week high-intensity interval exercise training programme on DAL in addition to usual 
care in patients with COPD. 
The study was approved by the University Hospital Ethics Committee (Protocol ID: 18367). One-
hundred fifty (150) consecutive patients with COPD were screened and referred for an outpatient 12-
week pulmonary rehabilitation programme between September 2011 and September 2015. During 
the study, 22 patients dropped out (15%). Baseline clinical assessment was part of the clinical care of 
COPD patients referred to the PR service. DAL was assessed for seven consecutive days prior to the 
start and following the completion of PR using a validated for COPD patients activity monitor 
(Actigraph GT3X,	Actigraph LLC Pensacola, FL) [9]. Activity monitoring data were analyzed by the 
ActiLife software version 5.10.10. Prior to the start of the PR programme patients were stratified for 
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DAL (i.e., >5000 vs <5000 steps/day) [10]. Following stratification patients were randomized in 2:1 
ratio into the Interval Training Group (ITG) or the Usual Care Group (UCG) [11]. Medical treatment 
was not altered throughout the study in either of the groups. Exclusion criteria for participation in PR 
programme have been described elsewhere [8]. Patients with a minimum of 4 valid days, including 
only days with at least 8 hours of wearing time during waking hours (as defined between 07:00am-
08:00pm) were contained in this analysis [12]. The interval programme included supervised exercise 
training consisting of cycling exercise 3 days/week for 12 weeks on electromagnetically braked cycle 
ergometers [7,8]. Patients assigned to ITG, exercised at a mean intensity of 130±18% of baseline 
peak work rate for 45 min by alternating 30-s exercise intervals with 30-s rest periods. The PR 
programme included resistance training for upper and lower limbs, breathing retraining, dietary advice 
and education programme.	No specific education session on changes in DAL was included. Data are 
reported as mean±SD. Normal distribution was assessed using the Shapiro-Wilk test revealing that all 
data were normally distributed. Baseline characteristics between the two groups were compared 
using independent paired t-test. Two-way ANOVA with repeated measures were employed to 
evaluate intervention x time interaction effects. Pair-wise differences were identified using Tukey’s 
honestly significant difference post hoc procedure.  
Baseline characteristics were similar between the two groups (Table 1). Significantly intervention x 
time interaction effects were observed between the ITG and the UCG for aerobic and functional 
capacities, respiratory symptoms, health related quality of life, emotional status and all physical 
activity outcomes (Table 1). ITG patients significantly and clinical meaningfully increased the mean 
number of steps/day (by 1094±1158 steps/day, or 27% from baseline value) and the time spent in 
lifestyle, light and moderate intensity of daily physical activities following the 12-week high-intensity 
interval training programme (Table 1). Furthermore, 38 out of 85 patients (45%) exhibited an increase 
of >1.000 steps/day whilst 6 more patients (7%) demonstrated an increase ranging between 900-
1000 steps/day. In addition, ITG patients had an increase over UCG of 1475±1358 steps/day or 36% 
from baseline value following the 12-week interval training programme. 
The present data demonstrate that in patients with COPD high-intensity interval exercise training 
as part of a comprehensive PR programme can induce clinically meaningful improvements in DAL in 
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terms of amount and intensity of daily physical activity. The importance of these novel findings is 
reinforced by the fact that the study was conducted in accordance with the recently published for 
COPD patients standardized procedure for DAL analysis [12] as well as by the inclusion of a control 
group [5].  
In the present study, the observed clinically meaningful increase in daily number of steps observed 
in the ITG group was accompanied by improvements in ventilatory, central hemodynamic and 
peripheral muscle capacities (Table 1). In view of the fact that intensity of the exercise training 
stimulus is a critical determinant of the magnitude of physiological adaptations that occur in response 
to training [13], interval training portraits as more favorable for COPD patients who are unable to 
sustain moderate intensities for long periods of time to achieve substantial physiological effects due to 
symptom limitations	of dyspnea and leg discomfort [4]. Therefore, it is concluded that induction of true 
physiological adaptations following interval training can be converted to clinically meaningful 
improvements in DAL in COPD patients. 
The content of the PR programme in the present study did not include physical activity counseling 
interventions. However, it is anticipated that the decrease in respiratory symptoms, the improvement 
in anxiety and depression emotional status and health related quality of life that was observed 
following interval rehabilitative exercise training, might have positively impacted on behavioral status 
and thus have further contributed to achieve meaningful improvements in DAL. However, future 
studies aiming at investigating the association between physiological and health related outcomes 
with behavioral status for physical activity are warranted in order to support the abovementioned 
arguments.  
Conventional rehabilitative exercise programmes have fallen short to show significant increases in 
time spent in moderate activities in patients with COPD [ref]. In this context, a recent study showed 
that training modalities mimicking everyday-life activities has proven to positively impact on DAL [14]. 
Interestingly, authors found that following 12 weeks of Nordic walking training, intensity of walking 
was significantly improved [14]. In our study we found that time spent in lifestyle and moderate 
activities significantly increased by 9±19 and 7±11 minutes/day, respectively. Thus, based on 
previous and these findings it can be concluded that interval training, which by some means mimics 
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the mode that patients with COPD perform everyday-life activities, can better be adapted into patients’ 
activity status compared to conventional constant-load exercise training programmes. 
To extent of our current knowledge, this is the first randomized control study demonstrating that 
high-intensity interval rehabilitative exercise training induces a clinically meaningful increase in DAL in 
patients with COPD.  
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Table 1. Outcomes before and after 12 weeks of high-intensity interval exercise training programme  
   
Variable Interval Training   
Group  
(n=85) 
Interval Training   
Group 
 (n=85) 
Usual Care  
Group 
(n=43) 
Usual Care  
Group 
 (n=43) 
 pre post pre post 
Demographics- Anthropometrics data 
Age, years 65 ± 8 
 
67 ± 8 
 Gender, male/female, (%) 67/17 (80) 36/7 (84) 
BMI, kg/m2 27.2 ± 4.7 27.3 ± 4.5 27.8 ± 5.2 27.7 ± 5.3 
FFMI, kg/m2 18.4 ± 2.9 18.6 ± 2.8 18.5 ± 2.61 18.6 ± 2.3 
Pulmonary function and disease related data 
FEV1, %predicted 48.8 ± 19.4 48.9 ± 19.1 44.9 ± 19.0 44.5 ± 19.2 
FEV1/FVC,% 51.8 ± 15.9 50.9 ± 16.3 48.0 ± 14.1 47.3 ± 13.9 
FRC, %predicted 159 ± 44 157 ± 43 167 ± 43 163 ± 40 
TLC, %predicted 119 ± 23 117 ± 22 125 ± 29 124 ± 29 
RV/TLC, % 52.6 ± 16.7 51.9 ± 10.4 56.2 ± 15.2 56.8 ± 15.8 
TLco, %predicted 59.3 ± 21.8 59.6 ± 23.1 55.0 ± 22.8 55.9 ± 23.0 
GOLD stages (I/II/IV/V), % (4/43/31/22) 
 
(5/39/35/21) 
 
Packs per year 52 ± 20 55 ± 19 
Number of Comorbidities/patient 1.3 ± 1.3 1.4 ± 1.7 
Number of Exacerbations/patient 1.11 ± 1.09 1.21 ± 1.11 
Number of Hospitalizations/patient 0.86 ± 0.73 0.88 ± 0.76 
Exercise variables and performance 
Peak work rate, watt 64 ± 29 82 ± 33* 66 ± 26 65 ± 19† 
Peak  O2 uptake, ml/min/100g 16.4 ± 3.9 17.8 ± 4.0* 15.7 ± 2.9 15.5 ± 4.1† 
Peak Minute Ventilation, L/min 45.5 ± 7.1 49.6 ± 9.4* 46.1 ± 8.7 45.3 ± 7.9† 
Peak Cardiac output, L/min 10.7 ± 2.1 12.5 ± 2.3* 10.2 ± 2.8 10.1 ± 2.5† 
6MWD, meters 387 ± 113 434 ± 121* 379 ± 106 373 ± 100† 
Quadriceps muscle force, kg 29.7 ± 11.9 33.9 ± 13.2* 30.4 ± 10.9 29.8 ± 11.1† 
Quadriceps muscle endurance, sec 31.5 ± 17.1 42.6 ± 16.7* 32.6 ± 18.6 33.1 ± 18.1† 
Symptoms,  Health related quality of life and Emotional status 
mMRC, scale 2.26 ± 1.04 1.6 ± 1.07* 2.37 ± 0.92 2.24 ± 0.99† 
CAT,  score 16.0 ± 6.1 12.1 ± 5.3* 16.3 ± 7.0 15.4 ± 8.0† 
CCQ, total score  1.90 ± 1.0 1.48 ± 1.0* 1.95 ± 0.9 2.00 ± 0.9† 
CRDQ, total score  86.4 ± 27.1 98.4 ± 21.6* 87.9 ± 23.8 89.1 ± 26.1† 
HADS, total score 13.6 ± 9.4 10.9 ± 8.0* 13.0 ± 7.9 12.8 ± 8.2† 
Daily Activity Levels (DAL) 
Sedentarism, % 69%  68%  
Wearing time (07:00am-08:00pm), min 765 ± 39 759 ± 49 755 ± 41 749 ± 40 
Daily number of steps 4043 ± 2484 5136 ± 2866* 3871 ± 2526 3453 ± 2493† 
Time spent in sedentary activities, min 576 ± 87 530 ± 97* 560 ± 82 566 ± 89† 
Time spent in light activities, min 135 ± 62 160 ± 67* 144 ± 56 137 ± 65† 
Time spent in lifestyle activities, min 39 ± 24 48 ± 32* 38 ± 26 34 ± 25† 
Time spent in moderate activities, min 13 ± 15 20 ± 19* 12 ± 19 12 ± 17† 
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Values are expressed as mean ±SD. * Within-group significant differences. † Between-groups significant 
differences (interval training group vs usual care group).  BMI: body mass index, FFMI: Fat free mass index. 
FEV1: forced expiratory volume in one second; FVC, forced vital capacity, FRC: functional residual capacity, RV: 
residual volume, TLC, total lung capacity, TLCO: diffusing capacity of the lung for carbon monoxide,	GOLD: Global 
Initiative for Obstructive Lung Disease 6MWD: six minute walk distance, mMRC: Modified Medical Research 
Council questionnaire, CAT: COPD Assessment Test, CCQ: Clinical COPD Questionnaire, CRDQ: Chronic 
Respiratory Disease Questionnaire, HADS: Hospital Anxiety Depression scale. Lung function was performed 
following ATS-ERS recommendations. Cardiac output assessed by impedance cardiography [11]. 6MWD 
measured as the best of 2 six minute walk tests, following ATS-ERS guidelines. Isometric quadriceps muscle 
force and endurance measured with the patient fixed in 90° hip and knee flexion [15]. Exacerbation history and 
Hospitalization refer to the last 12 months before enter the study. Sedentarism has been defined as a step count 
lower than 5000 steps/day [9]. 
 
